CANCER BIOLOGICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Cancer Biologics Market, By Product Type (Monoclonal Antibodies, Cytokines, Vaccines, Antibody-Drug Conjugates (ADCs), and Others), By Therapeutic Application (Hematologic Malignancies, SolidTumors, Personalized Cancer Vaccines, Immune Checkpoint Inhibitors, andOthers), By End User (Hospitals, Specialty Clinics, Research Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In: 26 Dec, 2025
Code: CMI4145
Formats: Excel and PDF
Industry: Biotechnology
- Historical Range: 2020 - 2024
- Forecast Period: 2025 - 2032

N/A

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Preview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Product Type
  - Market Snapshot, By Therapeutic Application
  - Market Snapshot, By End User
  - Market Snapshot, By Region
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
- Partnership Scenario
- Brand and Pricing Analysis
- Distributors Landscape
- Porters Analysis
- Technological Advancements
- Key Developments
- Market Trend
- Future Prospective
- Top Market Players by Revenue
Cancer Biologics Market By Product Type, 2025–2032, (US$ Billion)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021–2032
  - Segment Trends
- Monoclonal Antibodies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Cytokines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Antibody-Drug Conjugates (ADCs)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Cancer Biologics Market By Therapeutic Application, 2026-2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021–2032
  - Segment Trends
- Hematologic Malignancies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Solid Tumors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Personalized Cancer Vaccines
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Immune Checkpoint Inhibitors
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Cancer Biologics Market By End User, 2026-2033, (US$ Billion)
- Introduction
  - Market Share Analysis, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, 2021–2032
  - Segment Trends
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Research Institutes
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Specialty Clinics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
Cancer Biologics Market By Region, 2026-2033, (US$ Billion)
- Introduction
  - Market Share Analysis, By Region, 2025 and 2032 (%)
  - Y-o-Y Growth Analysis, For Regions, 2021–2032
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, en2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Benelux
    - Denmark
    - Norway
    - Sweden
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
    - China
    - Taiwan
    - India
    - Japan
    - Indonesia
    - Malaysia
    - Philippines
    - Singapore
    - Australia
    - South Korea
    - Rest of Asia Pacific

o Middle East & Africa

Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026-2033, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2026-2033, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2026-2033, (US$ Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2026-2033, (US$ Billion)
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- UAE
- Israel
- South Africa
- North Africa
- Central Africa
- Rest of the Middle East

Competitive Landscape
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AbbVie
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Gilead Sciences
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Takeda Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Celgene (A Bristol Myers Squibb Company)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CSL Limited
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sorrento Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Seattle Genetics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now